Mariel Otoso signed Galephar Pharmaceutical Research, Inc.'s 2025 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
Galephar Pharmaceutical Research, Inc.'s EIN is 66-0565645.
Download the official 2025 Form 5500 (PDF) for Galephar Pharmaceutical Research, Inc. from the U.S. Department of Labor's EFAST2 system.
Download the official 2025 Form 5500 (PDF)Galephar Pharmaceutical Research, Inc.'s plan includes long-term disability.
The Schedule of Assets is filed as a free-form PDF attachment on EFAST2; we parse these offline and coverage is partial (priority is the largest plans by EOY assets). This plan also reports no pooled (Schedule D) interests, so its holdings aren’t hidden on a master-trust filing. The line-item data lives on DOL EFAST2 under the same ACK_ID.
See Methodology > Data linkages for how Form 5500 / Schedule H / Schedule D / Schedule of Assets fit together.
